ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years

Weihao Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9301-8538; OpenAlex author ID A5101476783. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

The role of APOBEC mutagenesis in the progression and therapeutic guidance of pancreatic cancer. Co-author DOI 10.1016/j.ygeno.2025.111098 ↗
ABHD17C, a metabolic and immune-related gene signature, predicts prognosis and anti-PD1 therapy response in pancreatic cancer. Co-author DOI 10.1007/s12672-023-00690-7 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yongjie Xie · 2 shared papers, 2023–2025 · strength 0.45
- Paper The role of APOBEC mutagenesis in the progression and therapeutic guidance of pancreatic cancer. DOI 10.1016/j.ygeno.2025.111098 ↗
- Paper ABHD17C, a metabolic and immune-related gene signature, predicts prognosis and anti-PD1 therapy response in pancreatic … DOI 10.1007/s12672-023-00690-7 ↗
Weishuai Liu · 1 shared paper, 2025 · strength 0.25
- Paper The role of APOBEC mutagenesis in the progression and therapeutic guidance of pancreatic cancer. DOI 10.1016/j.ygeno.2025.111098 ↗
Bo Ni · 1 shared paper, 2025 · strength 0.25
- Paper The role of APOBEC mutagenesis in the progression and therapeutic guidance of pancreatic cancer. DOI 10.1016/j.ygeno.2025.111098 ↗
Xiaozhou Yu · 1 shared paper, 2025 · strength 0.25
- Paper The role of APOBEC mutagenesis in the progression and therapeutic guidance of pancreatic cancer. DOI 10.1016/j.ygeno.2025.111098 ↗
Tongguo Si · 1 shared paper, 2023 · strength 0.20
- Paper ABHD17C, a metabolic and immune-related gene signature, predicts prognosis and anti-PD1 therapy response in pancreatic … DOI 10.1007/s12672-023-00690-7 ↗
Xin Yu · 1 shared paper, 2023 · strength 0.20
- Paper ABHD17C, a metabolic and immune-related gene signature, predicts prognosis and anti-PD1 therapy response in pancreatic … DOI 10.1007/s12672-023-00690-7 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.